AllerGene AI Therapeutics

Seed
allergene.ai Biotech & Healthcare Miami, United States
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Jun 9, 2026
Investors Undisclosed
Decision Makers 2 Verified

About AllerGene AI Therapeutics

AllerGene AI Therapeutics is a biotechnology company developing in vivo mRNA-LNP CAR-T therapies.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Miami, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website allergene.ai
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for AllerGene AI Therapeutics.

Funding History

1 Round
Seed · Jun 9, 2026
Undisclosed

Founders & Leadership

1

Sid Kerkar

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts